# Ichor Biologics seeks $80-100M PE funding for minority stake

> Hyderabad biotech firm aims to raise $80-100 million from private equity to expand plasma therapy operations
- Title: Ichor Biologics seeks $80-100M PE funding for minority stake
- Summary: Hyderabad biotech firm aims to raise $80-100 million from private equity to expand plasma therapy operations Ichor Biologics needs $80-100 million from…
- Keywords: ichor biologics, plasmatherapy, private equity, hyderabad, therapeutic proteins, nfl, funding, biopharmaceutical, plasma processing, india, healthcare, Ichor
- Source: The Economic Times — https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/ichor-biologics-seeks-80-100-million-pe-funding-for-minority-stake-sale/articleshow/134396496.cms
- Author: Reghu Balakrishnan
- Published: 2026-09-21T18:34:00+00:00
- Read time: 1 min
- Topics: ichor biologics, plasmatherapy, private equity, hyderabad, therapeutic proteins, nfl, funding, biopharmaceutical, plasma processing, india, healthcare
## Ichor Biologics funding round
Hyderabad-based Ichor Biologics seeks $80-100 million from private equity investors for a minority stake sale
## Plasmatherapy specialist
Ichor operates in specialized plasmatherapy segment manufacturing therapeutic proteins for neurology, oncology, and organ transplantation
## Key stakeholders
Promoters Ananda Reddy Sudini and Sujana Sudini hold 50.5% and 44.5% stakes respectively with Time Cap Pharma Labs holding 5%
## Funding strategy
Alvarez & Marsal managing fundraising process with existing backers including UK's Artian Investments and FPrime Capital
## Market growth
India's plasma protein therapy market forecast to reach $500 million by 2030 growing at 4% annually
## Recent expansion
Ichor expanded plasma processing capacity to 281,000 liters from 130,000 liters by investing 165.33 crore in FY24
## Key takeaway

Ichor Biologics needs $80-100 million from private equity to scale its plasma therapy production capacity